---
title: "ADICON reshapes board as Carlyle Asia executive joins as non-executive director"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276715715.md"
description: "ADICON Holdings Limited has announced the resignation of non-executive director Feng Janine Junyuan due to changes in work arrangements, with no disagreements reported. The company has appointed Li Bo, a managing director at Carlyle Asia, as a new non-executive director, enhancing strategic oversight in the healthcare sector. The latest analyst rating for ADICON stock (HK:9860) is a Buy, with a price target of HK$8.60. ADICON operates in the healthcare sector and is backed by The Carlyle Group’s Asia arm, focusing on growth and operational enhancement."
datetime: "2026-02-24T09:39:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276715715.md)
  - [en](https://longbridge.com/en/news/276715715.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276715715.md)
---

# ADICON reshapes board as Carlyle Asia executive joins as non-executive director

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

ADICON Holdings Limited ( (HK:9860) ) has provided an announcement.

ADICON Holdings Limited has announced that non-executive director Feng Janine Junyuan has resigned from the board and its strategy committee, citing changes in work arrangements, with the company stressing there is no disagreement and thanking her for her contributions. The board has appointed Carlyle Asia managing director Li Bo, a veteran executive with extensive marketing and operational experience in healthcare and consumer sectors, as a new non-executive director, signaling continued alignment with its controlling shareholder and potentially strengthening strategic oversight and industry expertise at board level.

The most recent analyst rating on (HK:9860) stock is a Buy with a HK$8.60 price target. To see the full list of analyst forecasts on ADICON Holdings Limited stock, see the HK:9860 Stock Forecast page.

**More about ADICON Holdings Limited**

ADICON Holdings Limited is a Cayman Islands–incorporated company listed in Hong Kong that operates in the healthcare sector. Its controlling shareholder is The Carlyle Group’s Asia arm, indicating a strategic focus aligned with private equity–backed growth and operational enhancement in healthcare-related services and markets.

**Average Trading Volume:** 3,802,652

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$3.7B

For an in-depth examination of 9860 stock, go to TipRanks’ Overview page.

### Related Stocks

- [09860.HK](https://longbridge.com/en/quote/09860.HK.md)

## Related News & Research

- [ADICON Delays Shareholder Circular as Crown Bioscience Deal Awaits Regulatory Approvals](https://longbridge.com/en/news/286253929.md)
- [Investment giants join forces to form largest healthcare firm on the globe](https://longbridge.com/en/news/287091936.md)
- [Herbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to Europe | LUFFF Stock News](https://longbridge.com/en/news/286883156.md)
- [ELFI offers new private student loan alternative for medical and healthcare students facing federal loan changes](https://longbridge.com/en/news/286929682.md)
- [15:45 ET"Lean" Strengthens Saudi Arabia's Presence in Global Digital Health and Precision Medicine Ecosystems](https://longbridge.com/en/news/286811787.md)